UB Paderborn / Katalog / Suche / in CDI

Reducing glucocorticoid dosage improves serum osteocalcin in patients with rheumatoid arthritis—results from the TOMORROW study

Osteoporosis international, 2016-02, Vol.27 (2), p.729-735

2016

Volltextzugriff (PDF)

THU0098 No Relationship between Low Serum 25-Hydroxyvitamin D Level and Decreased Bone Mass or Bone Quality in Patients with Rheumatoid Arthritis – Tomorrow Study

Annals of the rheumatic diseases, 2016-06, Vol.75 (Suppl 2), p.214

2016

Volltextzugriff (PDF)

AB0376 Retention Rates and Clinical Efficacy of Tocilizumab as First-Line Biologics Compared To Second-Line in Patients with Rheumatoid Arthritis

Annals of the rheumatic diseases, 2016-06, Vol.75 (Suppl 2), p.1032-1033

2016

Volltextzugriff (PDF)

THU0112 Prevalence and Risk Factors for New Vertebral Fractures in Patients with RA: Five-Year Follow-up of The Tomorrow Study

Annals of the rheumatic diseases, 2016-06, Vol.75 (Suppl 2), p.220

2016

Volltextzugriff (PDF)

FRI0141 Bone Mineral Density of Whole Body Can Predict Fractures in Patients with Rheumatoid Arthritis: Findings from The Tomorrow Study

Annals of the rheumatic diseases, 2016-06, Vol.75 (Suppl 2), p.479-479

2016

Volltextzugriff (PDF)

FRI0105 Low Thoracic Bone Mineral Density and Glucocorticoid Are Risk Factors for Clinical Fractures in Patients with Rheumatoid Arthritis: Five-Year Findings of The Tomorrow Study

Annals of the rheumatic diseases, 2016-06, Vol.75 (Suppl 2), p.466

2016

Volltextzugriff (PDF)

FRI0062 Influence of Biologic Agents on Bone Mineral Density and Bone Mineral Markers in Patients with Rheumatoid Arthritis: Data from the Airtight Study

Annals of the rheumatic diseases, 2015-06, Vol.74 (Suppl 2), p.441

2015

Volltextzugriff (PDF)

AB0359 Sarcopenia is Apparent in Patients with Rheumatoid Arthritis, Especially Those Treated with Biologics -Tomorrow Study

Annals of the rheumatic diseases, 2015-06, Vol.74 (Suppl 2), p.1013-1013

2015

Volltextzugriff (PDF)

OP0219 Additional Intensive Treatment for Rheumatoid Arthritis Patients with Positive Power Doppler Signals Even After Achieving Clinical Remission Might Reduce the Radiological Joint Damage -Scrum Study

Annals of the rheumatic diseases, 2015-06, Vol.74 (Suppl 2), p.154-154

2015

Volltextzugriff (PDF)

FRI0084 High Levels of Anti-Cyclic Citrullinated Peptide Antibodies and High Doses of Glucocorticoid are Risk Factors for Falls in Patients with Rheumatoid Arthritis: Fourth-Year Results of the Tomorrow Study

Annals of the rheumatic diseases, 2015-06, Vol.74 (Suppl 2), p.450-450

2015

Volltextzugriff (PDF)

FRI0137 Medication Interval of Adalimumab for Rheumatoid Arthritis Patients Might be Extended After the Achievement of Low Disease Activity -Kabuki Study

Annals of the rheumatic diseases, 2015-06, Vol.74 (Suppl 2), p.471-471

2015

Volltextzugriff (PDF)

SAT0077 Ultrasonography as a Potent Tool for Predicting Radiographic Progression in Rheumatoid Arthritis Treated with Biological Agents

Annals of the rheumatic diseases, 2015-06, Vol.74 (Suppl 2), p.676-676

2015

Volltextzugriff (PDF)

Comparison of joint destruction between standard- and low-dose etanercept in rheumatoid arthritis from the Prevention of Cartilage Destruction by Etanercept (PRECEPT) study

Rheumatology (Oxford, England), 2012-12, Vol.51 (12), p.2164-2169

2012

Volltextzugriff (PDF)

SAT0136 Patients with Rheumatoid Arthritis and High Levels of Anti-Cyclic Citrullinated Peptide Antibody under Treatment with High-Dose Glucocorticoid Frequently Fall: Five-Year Findings of The Tomorrow Study

Annals of the rheumatic diseases, 2016-06, Vol.75 (Suppl 2), p.713

2016

Volltextzugriff (PDF)

SAT0135 Achieving Freedom from Glucocorticoids Might Decrease Risk of Clinical Fractures in Patients with Rheumatoid Arthritis: Five-Year Findings of The Tomorrow Study

Annals of the rheumatic diseases, 2016-06, Vol.75 (Suppl 2), p.713

2016

Volltextzugriff (PDF)

AB0209 Female Sex Increases The Risk of Forefoot Deformity in Patients with Rheumatoid Arthritis

Annals of the rheumatic diseases, 2016-06, Vol.75 (Suppl 2), p.969-969

2016

Volltextzugriff (PDF)

FRI0365 Very-High-Concentration Leptin Suppresses Aggravation of Collagen Antibody-Induced Arthritis in Mice

Annals of the rheumatic diseases, 2014-06, Vol.73 (Suppl 2), p.519-519

2014

Volltextzugriff (PDF)

FRI0077 Factors Predicting Change in Bone Mineral Density in Patients with Rheumatoid Arthritis: the Tomorrow Study

Annals of the rheumatic diseases, 2014-06, Vol.73 (Suppl 2), p.409

2014

Volltextzugriff (PDF)

FRI0022 Influence of Biologic Agents on Postoperative Infection in Rheumatoid Arthritis Patients

Annals of the rheumatic diseases, 2014-06, Vol.73 (Suppl 2), p.389

2014

Volltextzugriff (PDF)

AB0430 Effects of Abatacept and TNF Inhibitors Compared with Ultrasonography in Patients with Rheumatoid Arthritis

Annals of the rheumatic diseases, 2014-06, Vol.73 (Suppl 2), p.949-949

2014

Volltextzugriff (PDF)

FRI0064 Glucocorticoid is A Risk Factor for Fall and Fracture in Patients with Rheumatoid Arthritis: Third Year Results of the Tomorrow Study

Annals of the rheumatic diseases, 2014-06, Vol.73 (Suppl 2), p.404-405

2014

Volltextzugriff (PDF)

THU0368 Work Ability and Work Disability Evaluation in Patients with Rheumatoid Arthritis – from the Tomorrow Study

Annals of the rheumatic diseases, 2015-06, Vol.74 (Suppl 2), p.329

2015

Volltextzugriff (PDF)

AB0481 Abatacept Might not Alter Anti-Cyclic Citrullinated Peptide Levels in Established Rheumatoid Arthritis Patients -Airtight Study

Annals of the rheumatic diseases, 2015-06, Vol.74 (Suppl 2), p.1058-1058

2015

Volltextzugriff (PDF)

OP0010-HPR Intake of Monounsaturated Fatty Acids as Components of A Mediterranean Diet Suppresses Rheumatoid Arthritis Disease Activity – the Tomorrow Study

Annals of the rheumatic diseases, 2014-06, Vol.73 (Suppl 2), p.63-63

2014

Volltextzugriff (PDF)

Acquired leptin resistance by high-fat feeding reduces inflammation from collagen antibody-induced arthritis in mice

Clinical and experimental rheumatology, 2012-09, Vol.30 (5), p.707

2012

Volltextzugriff (PDF)

Menü

Weitere Dienste

Einstellungen

Reducing glucocorticoid dosage improves serum osteocalcin in patients with rheumatoid arthritis—results from the TOMORROW study

THU0098 No Relationship between Low Serum 25-Hydroxyvitamin D Level and Decreased Bone Mass or Bone Quality in Patients with Rheumatoid Arthritis – Tomorrow Study

AB0376 Retention Rates and Clinical Efficacy of Tocilizumab as First-Line Biologics Compared To Second-Line in Patients with Rheumatoid Arthritis

THU0112 Prevalence and Risk Factors for New Vertebral Fractures in Patients with RA: Five-Year Follow-up of The Tomorrow Study

FRI0141 Bone Mineral Density of Whole Body Can Predict Fractures in Patients with Rheumatoid Arthritis: Findings from The Tomorrow Study

FRI0105 Low Thoracic Bone Mineral Density and Glucocorticoid Are Risk Factors for Clinical Fractures in Patients with Rheumatoid Arthritis: Five-Year Findings of The Tomorrow Study

FRI0062 Influence of Biologic Agents on Bone Mineral Density and Bone Mineral Markers in Patients with Rheumatoid Arthritis: Data from the Airtight Study

AB0359 Sarcopenia is Apparent in Patients with Rheumatoid Arthritis, Especially Those Treated with Biologics -Tomorrow Study

OP0219 Additional Intensive Treatment for Rheumatoid Arthritis Patients with Positive Power Doppler Signals Even After Achieving Clinical Remission Might Reduce the Radiological Joint Damage -Scrum Study

FRI0084 High Levels of Anti-Cyclic Citrullinated Peptide Antibodies and High Doses of Glucocorticoid are Risk Factors for Falls in Patients with Rheumatoid Arthritis: Fourth-Year Results of the Tomorrow Study

FRI0137 Medication Interval of Adalimumab for Rheumatoid Arthritis Patients Might be Extended After the Achievement of Low Disease Activity -Kabuki Study

SAT0077 Ultrasonography as a Potent Tool for Predicting Radiographic Progression in Rheumatoid Arthritis Treated with Biological Agents

Comparison of joint destruction between standard- and low-dose etanercept in rheumatoid arthritis from the Prevention of Cartilage Destruction by Etanercept (PRECEPT) study

SAT0136 Patients with Rheumatoid Arthritis and High Levels of Anti-Cyclic Citrullinated Peptide Antibody under Treatment with High-Dose Glucocorticoid Frequently Fall: Five-Year Findings of The Tomorrow Study

SAT0135 Achieving Freedom from Glucocorticoids Might Decrease Risk of Clinical Fractures in Patients with Rheumatoid Arthritis: Five-Year Findings of The Tomorrow Study

AB0209 Female Sex Increases The Risk of Forefoot Deformity in Patients with Rheumatoid Arthritis

FRI0365 Very-High-Concentration Leptin Suppresses Aggravation of Collagen Antibody-Induced Arthritis in Mice

FRI0077 Factors Predicting Change in Bone Mineral Density in Patients with Rheumatoid Arthritis: the Tomorrow Study

FRI0022 Influence of Biologic Agents on Postoperative Infection in Rheumatoid Arthritis Patients

AB0430 Effects of Abatacept and TNF Inhibitors Compared with Ultrasonography in Patients with Rheumatoid Arthritis

FRI0064 Glucocorticoid is A Risk Factor for Fall and Fracture in Patients with Rheumatoid Arthritis: Third Year Results of the Tomorrow Study

THU0368 Work Ability and Work Disability Evaluation in Patients with Rheumatoid Arthritis – from the Tomorrow Study

AB0481 Abatacept Might not Alter Anti-Cyclic Citrullinated Peptide Levels in Established Rheumatoid Arthritis Patients -Airtight Study

OP0010-HPR Intake of Monounsaturated Fatty Acids as Components of A Mediterranean Diet Suppresses Rheumatoid Arthritis Disease Activity – the Tomorrow Study

Acquired leptin resistance by high-fat feeding reduces inflammation from collagen antibody-induced arthritis in mice

Suchergebnisse filtern